Differential substrate use in EGF- and oncogenic KRAS-stimulated human mammary epithelial cells.

ABSTRACT: Many metabolic phenotypes in cancer cells are also characteristic of proliferating nontransformed mammalian cells, and attempts to distinguish between phenotypes resulting from oncogenic perturbation from those associated with increased proliferation are limited. Here, we examined the extent to which metabolic changes corresponding to oncogenic KRAS expression differed from those corresponding to epidermal growth factor (EGF)-driven proliferation in human mammary epithelial cells (HMECs). Removal of EGF from culture medium reduced growth rates and glucose/glutamine consumption in control HMECs despite limited changes in respiration and fatty acid synthesis, while the relative contribution of branched-chain amino acids to the TCA cycle and lipogenesis increased in the near-quiescent conditi

SUBMITTER: Keibler MA 

PROVIDER: S-EPMC8487438 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature